ReviewNanophotonics (Berlin, Germany)2022
Spectroscopic ellipsometry for low-dimensional materials and heterostructures.
Review in Nanophotonics (Berlin, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- ReflectoRNN: AI-Enabled In-Operando Optical Reflectometry for Evolving Materials Using a Recurrent Neural Network.ACS nano · 2026Article
- Direct Synthesis of Ultrathin Hexagonal Boron Nitride Films on Si(001).Nano letters · 2026Article
- AI-based analysis algorithm incorporating nanoscale structural variations and measurement-angle misalignment in spectroscopic ellipsometry.Nanophotonics (Berlin, Germany) · 2025Article
- Bridging the scalability gap in van der Waals light guiding with high refractive index MoTeNanophotonics (Berlin, Germany) · 2025Article
- Tracking Lithium Intercalation in Battery Electrodes via Their Electrochromic Properties UsingJournal of the American Chemical Society · 2025Article
- Neural network-based analysis algorithm on Mueller matrix data of spectroscopic ellipsometry for the structure evaluation of nanogratings with various optical constants.Nanophotonics (Berlin, Germany) · 2025Article
- Spectroscopic Ellipsometry Study of the Temperature Dependences of the Optical and Exciton Properties of MoSMaterials (Basel, Switzerland) · 2024Article
- Deterministic reflection contrast ellipsometry for thick multilayer two-dimensional heterostructures.Nanophotonics (Berlin, Germany) · 2024Article
- Generic characterization method for nano-gratings using deep-neural-network-assisted ellipsometry.Nanophotonics (Berlin, Germany) · 2024Article
- Article
- Investigations of Optical Functions and Optical Transitions of 2D Semiconductors by Spectroscopic Ellipsometry and DFT.Nanomaterials (Basel, Switzerland) · 2023Article
- Non-Additive Optical Response in Transition Metal Dichalcogenides Heterostructures.Nanomaterials (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Discovery of low-dimensional materials has been of great interest in physics and material science. Optical permittivity is an optical fingerprint of material electronic structures, and thus it is an important parameter in the study of the properties of materials. Spectroscopic ellipsometry provides a fast, robust, and noninvasive method for obtaining the optical permittivity spectra of newly discovered materials. Atomically thin low-dimensional materials have an extremely short vertical optical path length inside them, making the spectroscopic ellipsometry of low-dimensional materials unique, compared to traditional ellipsometry. Here, we introduce the fundamentals of spectroscopic ellipsometry for two-dimensional (2D) materials and review recent progress. We also discuss technical challenges and future directions in spectroscopic ellipsometry for low-dimensional materials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.